Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Avanir Pharmaceuticals Announces Filing of IND for AVP-923 for the Treatment of Central Neuropathic Pain in Patients with Multiple Sclerosis
Yahoo
Monday, April 4, 2011 - 11:37am
tags:
neuropathic pain, MS, multiple sclerosis, AVP-923, Avanir
Vivus shares Qnexa study data
Yahoo/AP
Monday, April 4, 2011 - 9:29am
tags:
obesity, Vivus, Qnexa
KV Makena crisis shows brands can't underestimate the power of social media backlash
Wave
Monday, April 4, 2011 - 9:25am
tags:
social media, KV Pharmaceutical, Makena, drug pricing
Congress Had Power to Enact Health-Care Law, Obama Adminstration Argues
Bloomberg
Monday, April 4, 2011 - 9:16am
tags:
Obama, healthcare reform
Forest Labs. Extends Tender Offer To Buy Clinical Data Inc.
RTT News
Monday, April 4, 2011 - 9:14am
tags:
M&A, Clinical Data, Forest Labs
Glaxo in Talent War Amid Emerging-Market Race With Pfizer
Bloomberg
Monday, April 4, 2011 - 9:08am
tags:
GSK, Pfizer, emerging markets, India, China
Pfizer receives 'refuse to file' letter from FDA for compound tafamidis
Yahoo/AP
Monday, April 4, 2011 - 9:06am
tags:
FDA, tafamidis, Pfizer, transthyretin familial amyloid polyneuropathy
Analysis Flags Fears Over Avastin
WSJ Online
Monday, April 4, 2011 - 9:04am
tags:
Avastin, Lucentis, Roche, Novartis, off-label
Genzyme now offically a subsidiary of Sanofi-Aventis
Bizjournals.com
Monday, April 4, 2011 - 9:01am
tags:
Genzyme, Sanofi
Mylan says it is now selling generic version of Pfizer's glaucoma treatment Xalatan
Yahoo/AP
Monday, April 4, 2011 - 9:00am
tags:
Mylan, generics, Pfizer, Xalatan
PDI Announces Contract Extension Valued at $23M
Benzinga
Monday, April 4, 2011 - 8:51am
tags:
PDI Pharma, contract sales
KKR Agrees To Buy Pfizer's Capsugel Unit; FDA Deems Application Incomplete
WSJ Online
Monday, April 4, 2011 - 8:49am
tags:
FDA, M&A, Pfizer, Capsugel, KKR
Actelion board nominees deny sale is main aim
Reuters
Monday, April 4, 2011 - 8:45am
tags:
M&A, Actelion
Novo Nordisk Patents Synthetic Gut Hormone in Obesity-Drug Plan
Bloomberg
Monday, April 4, 2011 - 8:36am
tags:
Novo Nordisk, obesity, patents
Merck, J&J’s New Hepatitis C Treatments Fetch $31,000 in France
Bloomberg
Monday, April 4, 2011 - 8:34am
tags:
Merck, JNJ, hepatitis C, France, Vertex Pharmaceuticals, Telaprevir, Boceprevir
Lilly Sees Big Opportunity in China
Seeking Alpha
Monday, April 4, 2011 - 8:32am
tags:
China, Eli Lilly
Roche Tarceva Drug's Use in Lung Cancer Predicted in Cancer Cell Genes
Bloomberg
Sunday, April 3, 2011 - 9:29am
tags:
Roche, lung cancer, Tarceva
Dendreon Faces Internet-Fueled Shareholder Uprising
Motley Fool
Sunday, April 3, 2011 - 9:28am
tags:
shareholders, Dendreon
Pernix Remains Way Too Cheap
Seeking Alpha
Sunday, April 3, 2011 - 9:26am
tags:
earnings, Pernix
Pfizer, Lilly Antidepressants Linked to Narrowed Arteries in Older Men
Bloomberg
Sunday, April 3, 2011 - 9:23am
tags:
antidepressants, Eli Lilly, Pfizer, Forest Labs, Lexapro, Cymbalta, Zoloft

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.